Serotonin 5-HT3 Receptor Antagonists for Nausea and Vomiting (oral)

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Revision history
    • October 20, 2022; September 2020; July 2018; September 2016; June 2015; October 2013; November 2011; September 2011; October 2009; December 2005; August 2003; July 2002; July 2001; August 2000; August 1999; July 1998; July 1997.
  • Initially developed
    • Sept. 1996